tiprankstipranks
Vor Biopharma (VOR)
NASDAQ:VOR
US Market
VOR
Vor Biopharma
RESEARCH TOOLSreports

Vor Biopharma (VOR) Stock News & Sentiment

959 Followers
Vor Biopharma: Solid Clinical Execution and Strengthened Balance Sheet Support Buy Rating and Long-Term Growth Outlook
Premium
Ratings
Vor Biopharma: Solid Clinical Execution and Strengthened Balance Sheet Support Buy Rating and Long-Term Growth Outlook
10d ago
VOR
Vor Biopharma: Strategic Autoimmune Pivot and Telitacicept’s >$2B gMG/SjD Opportunity Underpins Buy Rating
Premium
Ratings
Vor Biopharma: Strategic Autoimmune Pivot and Telitacicept’s >$2B gMG/SjD Opportunity Underpins Buy Rating
11d ago
VOR
Vor Biopharma Announces $75 Million Private Placement Financing
Premium
Company Announcements
Vor Biopharma Announces $75 Million Private Placement Financing
13d ago
8K
VOR
VOR Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
VOR Earnings this Week: How Will it Perform?
23d ago
VOR
Vor Biopharma to Highlight Telitacicept at JPM Conference
Premium
Company Announcements
Vor Biopharma to Highlight Telitacicept at JPM Conference
3M ago
8K
VOR
Vor Biopharma CDO Departs, Transition Support Planned
Premium
Company Announcements
Vor Biopharma CDO Departs, Transition Support Planned
3M ago
8K
VOR
Vor Biopharma strengthens board following $150M private placement
Premium
Company Announcements
Vor Biopharma strengthens board following $150M private placement
4M ago
8K
VOR
More VOR News >

VOR News on the Web

Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Vor Biopharma (VOR) and Bristol-Myers Squibb (BMY)
TipRanks News
Neutral
Major Insider Move Rocks Vor Biopharma as Director Unloads Massive Stake
TipRanks News
Neutral
Vor Biopharma (VOR) Upgraded to Buy: Here's Why
Zacks
Bullish
Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know
Zacks
Neutral
Vor Bio price target raised to $15 from $9 at Wedbush
TipRanks News
Neutral
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Neutral
Vor Bio price target lowered to $40 from $55 at Stifel
TipRanks News
Bearish
Vor Biopharma: Solid Clinical Execution and Strengthened Balance Sheet Support Buy Rating and Long-Term Growth Outlook
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
VOR
Sector Average
Media Buzz
This Week2 articles
Weekly Average4.5 articles
News Sentiment
This Week50%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VOR’s Media Buzz Sentiment?
2 articles about VOR were published this week. In an average week, 4.5 articles are published.
    What is VOR’s weekly average amount of articles?
    In an average week, 4.5 articles about VOR are published.
      What is VOR’s News Sentiment?
      50% of articles about VOR were positive this week, compared to its sector average of 69%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        AORTArtivion
        OWLTOwlet
        STAAStaar Surgical
        ORGOOrganogenesis Holdings
        Showing the stocks with the most bullish news sentiment over the past week